February 5, 2021 – The Bowdoin Group recently placed Bruno Lempernesse as CEO of oncology-focused health technology company Carevive Systems. The search was spearheaded by Josh Gottlieb, managing director, digital health, and Sean Walker, partner.
Mr. Lempernesse, a veteran health technology executive at the forefront of real-world patient data, joins company co-founder Madelyn Trupkin Herzfeld in leading Carevive. “We’re extremely happy for Bruno, Maddy and the rest of the team at Carevive on this exciting news,” said Mr. Walker. “I’ve known Bruno for 10 years and he’s a true professional who brings a terrific mix of both small and large company experience to the table. His background in real-world evidence and pharma combined with Maddy’s expertise will enable the two of them to grow the company exponentially, all while improving outcomes for cancer patients.”
“Bruno is a seasoned, high-growth executive and is also an expert in generating and analyzing real-world data,” said Ms. Herzfeld. “We have a meaningful vision to make cancer care better for patients and their families. Bruno’s experience in growing successful real-world evidence companies and my oncology expertise are the perfect complement to scale the company, and we have shared passion to ensure our vision becomes a reality. Despite the explosion in the new cancer treatments approved by regulators there is an unmet need for reporting of real-world patient experiences and outcomes with each of these treatments. As we look to the future, Carevive data will be key to providing those insights.”
Ms. Herzfeld will continue to serve as director, and take on the role of vice chairman, in which she will oversee oncology practice and health system network partnerships, and chair Carevive’s strategic advisory board. The two will partner on corporate development relationships as well as the company’s overall growth strategy.
Mr. Lempernesse joins Carevive from Acorn AI, a Medidata company, having led their commercial data solutions division. His 25-year experience at the intersection of real-world patient data analytics and corporate leadership leaves him perfectly positioned to bring Carevive’s technologies to the entire cancer care ecosystem. Mr. Lempernesse was previously a senior vice president and general manager at SHYFT Analytics. His other experiences in advancing healthcare data analytics include serving as CEO at Inflexxion and multiple executive global roles at Cegedim.
Under Mr. Lempernesse’s leadership, the company plans to accelerate its vision to collect and analyze real-world patient-reported outcomes and care pathways to continuously improve upon the cancer care experience across the U.S. “Multiple stakeholders have an interest in connecting clinical data and patient-reported outcomes data, including life science companies, clinicians and payers, in order to improve patient care,” said Mr. Lempernesse. “With a committed team, board and co-founder, Carevive will reshape the way cancer care is delivered, and make treatments and therapies more personalized. I’m pinching myself knowing that I found a company with not only massive growth potential but with the patient at the center – the possibilities are endless.”
Carevive Systems, founded in 2013, is an oncology-focused health technology company focused on understanding and improving the cancer patient experience.
Veteran Search Firm
Founded in 1994, The Bowdoin Group specializes in leadership and strategic roles for a wide range of companies, from small firms building out their executive team to large firms sourcing talent for rapid market expansion as well as venture- and private equity-backed firms. With deep expertise in biopharma, digital health, fintech and financial services, and software, the firm specializes in the Greater Boston area with the ability to source talent and service companies globally.
The Bowdoin Group Forms Alliance with QPS to Further DE&I Initiatives
The Bowdoin Group formed a strategic partnership with the diversity, equity and inclusion service provider Quantum Power Skills (QPS). “This has been and continues to be a business imperative for us, both internally and external for our clients,” said Mr. Melville. “We have worked hard to understand what we as a firm can do to improve ourselves and the market around us, but we can no longer afford to continue with business as usual. We must leverage and embrace the principles around DE&I to create the highest performing companies and teams we can; that’s our job.”
Mr. Gottlieb has 12 years of executive search experience, working with executives and investors to help them build their executive and commercial teams. As managing director, digital health, he works with venture-backed, PE-backed, and high growth companies that are solving the biggest issues facing payer, provider, biopharma and employers with the goal of positively impacting patient outcomes. His primary responsibilities include partnering closely with clients and their boards, providing them guidance on talent acquisition strategy, team expansions, and executive and strategic searches.
Mr. Walker has over 25 years of search, sales, and business development experience with venture-backed and emerging growth companies in the innovation economy. As a partner at The Bowdoin Group, he started a number of the firm’s practices, including the digital health and healthtech practice. Mr. Walker is deeply integrated in the digital health ecosystem, working closely with BoDs, VC firms and PE firms to define their go-to-market strategies and help them understand and define the types of C-level leaders they want and need. He is also responsible for partnering extensively with clients and advising their talent acquisition strategy, large hiring projects, and executive and strategic searches.
Contributed by Scott A. Scanlon, Editor-in-Chief; Dale M. Zupsansky, Managing Editor; and Stephen Sawicki, Managing Editor – Hunt Scanlon Media